Breaking News Bar

Business News and Information

The Pharma Four: Similar ETFs, Different Returns

By: ETFdb
Pharmaceutical companies have long been popular investments as they offer relatively inelastic products as well as strong dividend yields that give both growth and value investors something to buy into. As far as the ETF world is concerned, there are four products that allow investors to gain access to this investment class. But with the four products being very similar, it can be difficult to pick and choose one ETF over the other. While underlying holdings or investment strategies may be similar, the returns of these products has been drastically different over the last few years, which may swing investors one way or the other on these ETFs [see also Three Things Wall Street Journal Didn’t Tell You About Commodities]. HOLDRS Merrill Lynch Pharmaceutical (PPH) This HOLDRS fund debuted in 2000 and is an investor favorite, with nearly $500 million in assets and an average daily volume well over 300,000. [...] Click here to read the original article on ETFdb.com. Related Posts: Return of Swine Flu: Pharma ETFs In Focus Will Obamacare Put Healthcare ETFs On Life Support? ETF Insider: Equities Poised To Pop Pharma ETFs Rise on Swine Flu Pandemic News ETF Shakeup: HOLDRS Headed For Extinction, ELEMENTS To Follow?
Pharmaceutical companies have long been popular investments as they offer relatively inelastic products as well as strong dividend yields that give both growth and value investors something to buy into. As far as the ETF world is concerned, there are four products that allow investors to gain access to this investment class. But with the four products being very similar, it can be difficult to pick and choose one ETF over the other. While underlying holdings or investment strategies may be similar, the returns of these products has been drastically different over the last few years, which may swing investors one way or the other on these ETFs [see also Three Things Wall Street Journal Didn’t Tell You About Commodities]. HOLDRS Merrill Lynch Pharmaceutical (PPH) This HOLDRS fund debuted in 2000 and is an investor favorite, with nearly $500 million in assets and an average daily volume well over 300,000. [...]

Click here to read the original article on ETFdb.com.

Related Posts:

Advertisement

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear